Sign up to SCR Digest, our FREE weekly newsletter, and receive our Notes emailed directly to you. Click here.

SNES: AB-1788, the use of second generation anticoagulants, passed the California Legislature and the Governor now has less than 15 days to approve it.

09/02/2020

By Ian Gilson, PhD, CFA

NASDAQ:SNES

READ THE FULL SNES RESEARCH REPORT

California AB-1788 was passed by the California Legislature on August 28, 2020 and was sent to the Governor for his signature. He has 15 days to approve it (we assume those are 15 in session days).

The bill requires a reevaluation of the use of second generation anticoagulants that “continued use is not reasonably expected to result in significant adverse effects to non-target wildlife”.

The bill will regulate the use of second generation anticoagulant rodenticides (SGARs) until the Director of Pesticide Regulation certifies to the Secretary of State that the Department of Pesticide Regulation has completed the reevaluation.

It will take some time before the additional requirements are completed and we do not expect any immediate impact on sales and earnings of SenesTech Inc.

SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR. 

DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks provides and Zacks receives quarterly payments totaling a maximum fee of $40,000 annually for these services. Full Disclaimer HERE.

 
User ID:
Password:
Remember my ID: